doi: 10.1016/S2213-8587(17)30412-6 61 Abd El AzizMSKahleMMeierJJNauckMA
A phase II clinical trial is underway to evaluate the combination of BA3011 and durvalumab in patients with platinum-resistant HGSOC (NCT04918186)
Modest changes in systolic blood pressure or arrhythmia burden were reported, but the evidence remains limited and heterogeneous
For those curious about the newest options, the three-way comparison between semaglutide, tirzepatide, and retatrutide covers how each medication differs in GI side effect profiles
That persistent drip can cause a sore, raw feeling, throat clearing, and a chronic cough
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Changes to menstrual cycles are not listed as specific side effects in the prescribing information for tirzepatide